Company intelligence / Profile preview

Ovalum

Ownership
Private
Development stage
Commercial
01

Overview

Ovalum Ltd. was a privately held medical device company founded in 2005 with the goal to develop and commercialize safe and effective technologies for vascular interventions. The company's main achievement reported was the announcement in February 2008 that its proprietary technology had been used successfully for the first time in US clinical procedures. There have been no further public updates about products, leadership, funding rounds, acquisitions, or ongoing operations since that time—suggesting that Ovalum Ltd. may now be inactive or defunct as there are also no active website or business directory listings found after this period.

Therapeutic areas
Cardiovascular
Modalities
Device
Industry
Surgical Medical Devices
02

Drug pipeline

2 assets

CGuard EPS

Commercial
Indications
Carotid artery disease

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Ovalum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovalum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call